Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves heart function and repairs damage after heart attack in mice.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Five FDA-approved drugs may help block COVID-19 virus entry.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Blocking α1-integrin makes adult fibroblasts more like foetal ones, improving their movement and aiding wound healing.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.